1,073 results on '"Silverman, Earl"'
Search Results
102. NEONATAL LUPUS ERYTHEMATOSUS
103. Systemic Lupus Erythematosus
104. Radiographic vertebral morphology: A diagnostic tool in pediatric osteoporosis
105. Chondrodysplasia punctata associated with maternal autoimmune diseases: Expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases
106. Feasibility and Effectiveness of an Aerobic Exercise Program in Children With Fibromyalgia: Results of a Randomized Controlled Pilot Trial
107. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
108. Osteoporosis, vitamin D deficiency, and supplementation in juvenile systemic lupus erythematosus: Comment on the article by Compeyrot-Lacassagne et al
109. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform
110. The Effects of Vigorous Exercise Training on Physical Function in Children With Arthritis: A Randomized, Controlled, Single-Blinded Trial
111. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis
112. Prevalence and Etiology of Low Bone Mineral Density in Juvenile Systemic Lupus Erythematosus
113. Hydrocephalus and macrocephaly: New manifestations of neonatal lupus erythematosus
114. Pediatric systemic lupus erythematosus
115. Longitudinal Examination of Lipid Profiles in Pediatric Systemic Lupus Erythematosus
116. Leflunomide in juvenile idiopathic arthritis
117. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus
118. Primary central nervous system vasculitis in children
119. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus
120. Angiography-Negative Primary Central Nervous System Vasculitis in Children: A Newly Recognized Inflammatory Central Nervous System Disease
121. Long-Term Open-Label Preliminary Study of the Safety and Efficacy of Leflunomide in Patients With Polyarticular-Course Juvenile Rheumatoid Arthritis
122. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis
123. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus
124. European Consensus Lupus Activity Measurement Is Sensitive to Change in Disease Activity in Childhood-Onset Systemic Lupus Erythematosus
125. Incidence and spectrum of neonatal lupus erythematosus: A prospective study of infants born to mothers with anti-RO autoantibodies
126. Thrombotic thrombocytopenic purpura in a patient with Behçetʼs disease
127. Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease
128. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease
129. Fetal Echocardiographic Screening of Pregnancies of Mothers with Anti-Ro and/or Anti-La Antibodies
130. Risk Factors for Damage in Childhood-Onset Systemic Lupus Erythematosus: Cumulative Disease Activity and Medication Use Predict Disease Damage
131. THROMBOEMBOLISM IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES.
132. Cardiovascular risk factors after Kawasaki disease: A case-control study
133. EARLY PREDICTORS OF POOR FUNCTIONAL OUTCOME IN SYSTEMIC-ONSET JUVENILE RHEUMATOID ARTHRITIS: A Multicenter Cohort Study
134. Management and Outcome of Persistent or Recurrent Fever After Initial Intravenous Gamma Globulin Therapy in Acute Kawasaki Disease
135. Recognition and management of Kawasaki disease
136. MOESM1 of Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease
137. CLOSE RELATIONSHIP BETWEEN SYSTEMIC LUPUS ERYTHEMATOSUS AND THROMBOTIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
138. SENSITIVITY OF THE SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX, BRITISH ISLES LUPUS ASSESSMENT GROUP INDEX, AND SYSTEMIC LUPUS ACTIVITY MEASURE IN THE EVALUATION OF CLINICAL CHANGE IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS
139. The health of mothers of children with cutaneous neonatal lupus erythematosus differs from that of mothers of children with congenital heart block
140. Coughing up clues: 16-year-old girl with acute haemoptysis
141. Earlier use of systemic immunosuppression is associated with fewer ophthalmic surgeries in paediatric non-infectious uveitis
142. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE
143. FRI0533 ETHNICITY AND NEONATAL LUPUSRISK IN A LARGE MULTI-ETHNIC COHORT
144. 60 Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset with SLE
145. Diagnosis and management of stenotic aorto-arteriopathy in childhood
146. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus
147. Systemic lupus erythematosus in childhood
148. Predicting Macrophage Activation Syndrome in Childhood-onset Systemic Lupus Erythematosus Patients at Diagnosis.
149. Seasonal onset of systemic-onset juvenile rheumatoid arthritis
150. Accelerated nodulosis during methotrexate therapy for juvenile rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.